Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Easley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Pathology|December 9, 2009
Experimental botryomycosisP Kimmelstiel, C A Easley
The Journal of Urology|December 1, 1974
Advanced carcinoma of bladder: treatment using hypogastric artery infusion with 5-fluorouracil, either as a single agent or in combination with bleomycin or adriamycin and supervoltage radiationJ E Nevin, I Melnick, J T Baggerly, et al.
Virginia Medical Monthly|August 1, 1975
Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostateJ E Nevin, I Melnick, J T Baggerly, et al.
The Journal of Urology|July 1, 1974
Arterial infusion of 5-fluorouracil as a treatment for carcinoma of the prostateJ E Nevin, I Melnick, J T Baggerly, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Pathology|December 9, 2009
Experimental botryomycosisP Kimmelstiel, C A Easley
The Journal of Urology|December 1, 1974
Advanced carcinoma of bladder: treatment using hypogastric artery infusion with 5-fluorouracil, either as a single agent or in combination with bleomycin or adriamycin and supervoltage radiationJ E Nevin, I Melnick, J T Baggerly, et al.
Virginia Medical Monthly|August 1, 1975
Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostateJ E Nevin, I Melnick, J T Baggerly, et al.
The Journal of Urology|July 1, 1974
Arterial infusion of 5-fluorouracil as a treatment for carcinoma of the prostateJ E Nevin, I Melnick, J T Baggerly, et al.
Pageof 1